77 Stocks Moving In Tuesday's Mid-Day Session
Gainers
- Biohaven Pharmaceutical Holding Company Ltd. NASDAQ:BHVN shares jumped 70.8% to
$142.01 . Pfizer Inc NYSE:PFE will acquire Biohaven Pharmaceutical Holding for$148.50 per share, equivalent to$11.6 billion . - Vroom, Inc. NASDAQ:VRM shares gained 38.4% to
$1.4950 after the company reported better-than-expected Q1 results. - Appian Corporation NASDAQ:APPN gained 34.5% to
$57.86 . Appian was awarded$2.036 billion in damages against Pegasystems Inc.. - AdaptHealth Corp. NASDAQ:AHCO shares climbed 25.9% to
$14.39 after the company reported upbeat Q1 sales and announced a$200 million buyback. - CECO Environmental Corp. NASDAQ:CECE gained 24.7% to
$5.30 after the company posted upbeat Q1 results and announced the purchase of Compass Water Solutions. - Assertio Holdings, Inc. NASDAQ:ASRT rose 23.1% to
$2.3150 after the company reported better-than-expected Q1 EPS and sales results. - Aurinia Pharmaceuticals Inc. NASDAQ:AUPH gained 22.2% to
$10.93 following strong quarterly sales. - ShockWave Medical, Inc. NASDAQ:SWAV jumped 21.1% to
$140.38 after the company reported better-than-expected Q1 results and raised its FY22 sales guidance to above analyst estimates. - FibroGen, Inc. NASDAQ:FGEN gained 20.2% to
$9.55 after the company reported better-than-expected Q1 EPS results. - The Pennant Group, Inc. NASDAQ:PNTG jumped 19.7% to
$15.32 following strong quarterly results. - Myovant Sciences Ltd. NYSE:MYOV gained 19% to
$9.26 following Q4 earnings. - Intra-Cellular Therapies, Inc. NASDAQ:ITCI gained 18.6% to
$50.97 after reporting narrower-than-expected quarterly loss. - Angi Inc. NASDAQ:ANGI jumped 18% to
$4.2350 following upbeat quarterly sales. - Cyngn Inc. NASDAQ:CYN gained 17.8% to
$5.01 . - Cara Therapeutics, Inc. NASDAQ:CARA gained 17.7% to
$8.77 after reporting upbeat quarterly results. - Y-mAbs Therapeutics, Inc. NASDAQ:YMAB jumped 16.8% to
$9.61 following narrower-than-expected quarterly loss. - Park-Ohio Holdings Corp. NASDAQ:PKOH gained 16.6% to
$11.50 after the company reported better-than-expected Q1 sales results and EPS results were higher year over year. - Haemonetics Corporation NYSE:HAE gained 16.5% to
$57.41 following better-than-expected quarterly results. - Nuvation Bio Inc. NYSE:NUVB jumped 16.1% to
$4.91 after the company posted a narrower quarterly loss. - Cronos Group Inc. NASDAQ:CRON rose 14.4% to
$3.24 following Q1 results. - Cortexyme, Inc. NASDAQ:CRTX gained 14% to
$3.74 . Cortexyme agreed to acquire privately held Novosteo, which is focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury. - Coupang, Inc. NYSE:CPNG jumped 13.3% to
$10.60 . - OPKO Health, Inc. NASDAQ:OPK jumped 12.7% to
$2.75 following Q1 results. - Seagen Inc. NASDAQ:SGEN gained 12.2% to
$122.25 . The Board of Directors of Seagen announced that its long-time president, CEO, and chairmanClay Siegall , is on a leave of absence. - Color Star Technology Co., Ltd. NASDAQ:CSCW rose 12.1% to
$0.1278 after dropping 12% on Monday. - Nutex Health, Inc. NASDAQ:NUTX rose 11.4% to
$5.18 after declining 22% on Monday. - LivePerson, Inc. NASDAQ:LPSN rose 10.9% to
$18.08 following Q1 results. - NeuroBo Pharmaceuticals, Inc. NASDAQ:NRBO rose 9.5% to
$0.5113 after tumbling 23% on Monday. - Evolve Transition Infrastructure LP NYSE:SNMP rose 7.8% to
$0.4398 after declining around 7% on Monday. - Cenntro Electric Group Limited NASDAQ:CENN rose 7.1% to
$1.5850 . Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles. - Clover Health Investments, Corp. NASDAQ:CLOV rose 5.4% to
$2.54 after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.
Losers
- Upstart Holdings, Inc. NASDAQ:UPST shares dipped 56.7% to
$33.38 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates. - Kaleyra, Inc. NYSE:KLR dipped 38.8% to
$3.7250 after the company reported worse-than-expected Q1 EPS and sales results and issued Q2 and FY22 sales guidance below analyst estimates. - United Insurance Holdings Corp. NASDAQ:UIHC fell 38.5% to
$1.3770 after the company reported a wider Q1 core loss. - Embark Technology, Inc. NASDAQ:EMBK dropped 37.8% to
$2.1696 . - Cipher Mining Inc. NASDAQ:CIFR fell 36.2% to
$2.06 . Cipher Mining posted a Q1 loss of$0.07 per share. - Desktop Metal, Inc. NYSE:DM dropped 35.3% to $2.2101 following wider-than-expected quarterly loss.
- Akanda Corp. NASDAQ:AKAN dipped 28% to
$1.6291 . - FutureFuel Corp. NYSE:FF fell 28.7% to
$7.04 after the company said Q1 EPS results were lower year over year. - Diebold Nixdorf, Incorporated NYSE:DBD fell 28% to
$2.7350 after the company posted downbeat quarterly results and lowered sales guidance. - Enochian Biosciences, Inc. NASDAQ:ENOB fell 27.8% to
$4.65 . - Tenon Medical, Inc. NASDAQ:TNON fell 26.8% to
$36.42 . - Bausch Health Companies Inc. NYSE:BHC fell 26.4% to
$9.49 after the company reported Q1 sales results were down year over year and cut FY22 guidance. - Huadi International Group Co., Ltd. NASDAQ:HUDI dipped 26.4% to
$21.20 . - GoodRx Holdings, Inc. NASDAQ:GDRX shares fell 25.7% to
$7.99 after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates. - National Vision Holdings, Inc. NASDAQ:EYE dropped 25.4% to
$25.04 as the company lowered FY22 guidance. - FTC Solar, Inc. NASDAQ:FTCI fell 24.9% to
$2.4699 following downbeat quarterly results. - CarGurus, Inc. NASDAQ:CARG fell 24.4% to
$22.56 after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates. - Spark Networks SE NASDAQ:LOV dipped 20.7% to
$1.64 following Q1 results. - loanDepot, Inc. NYSE:LDI dropped 20.3% to
$2.15 as the company swung to a loss in the first quarter. - Cvent Holding Corp. NASDAQ:CVT fell 19.6% to
$4.3050 following Q1 results. - AppFolio, Inc. NASDAQ:APPF dipped 18.8% to
$80.99 after reporting a loss for the first quarter. - Infrastructure and Energy Alternatives, Inc. NASDAQ:IEA dropped 18.3% to
$7.01 following wider-than-expected quarterly loss. - LogicBio Therapeutics, Inc. NASDAQ:LOGC fell 17.8% to
$0.5487 . LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia. - StarTek, Inc. NYSE:SRT declined 17.2% to
$3.3350 following Q1 results. - TaskUs, Inc. NASDAQ:TASK dropped 16.4% to
$19.50 following Q1 results. - Wejo Group Limited NASDAQ:WEJO declined 16.2% to
$2.18 . - Babcock & Wilcox Enterprises, Inc. NYSE:BW fell 16% to
$5.96 following wider-than-expected quarterly loss. - FreightCar America, Inc. NASDAQ:RAIL dropped 15.4% to
$4.29 after reporting Q1 loss. - Village Farms International, Inc. NASDAQ:VFF dipped 15.1% to
$3.26 following weak quarterly results. - Benson Hill, Inc. NYSE:BHIL fell 14.6% to
$2.4550 . - Local Bounti Corporation NYSE:LOCL declined 14.5% to
$4.40 following Q1 results. - Lightwave Logic, Inc. NASDAQ:LWLG fell 14.4% to
$8.02 . - Eve Holding Inc. NYSE:EVEX dropped 14.3% to
$9.70 . Eve Holding reported that its common stock will begin trading on NYSE today under the symbol 'EVEX.' - Science 37 Holdings, Inc. NASDAQ:SNCE dropped 14% to
$3.19 . Science 37 Holdings reported better-than-expected Q1 EPS and sales results. - Starry Group Holdings, Inc. NYSE:STRY fell 14% to
$7.22 . - Dave Inc. NASDAQ:DAVE dipped 13.3% to
$2.29 . - Vivid Seats Inc. NASDAQ:SEAT dropped 12.7% to
$7.52 following Q1 results. - Veeco Instruments Inc. NASDAQ:VECO fell 11.8% to
$20.08 after the company issued weak earnings forecast. - Matrix Service Company NASDAQ:MTRX dropped 11.6% to
$5.74 following wider Q3 loss. - TrueCar, Inc. NASDAQ:TRUE fell 11.5% to
$3.13 . TrueCar posted a Q1 net loss of$12.4 million . - Aterian, Inc. NASDAQ:ATER shares fell 11.5% to
$3.5301 after the company reported worse-than-expected Q1 sales results. - Affirm Holdings, Inc. NASDAQ:AFRM fell 11.4% to
$18.25 after Upstart reported financial results and issued guidance below analyst estimates. - Revlon, Inc. NYSE:REV fell 11.4% to
$4.5093 . Revlon recently posted a Q1 loss of$1.14 per share. - Groupon, Inc. NASDAQ:GRPN fell 10.6% to
$13.99 after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance. - Novavax, Inc. NASDAQ:NVAX fell 9.5% to
$48.19 as the company posted downbeat results for its first quarter on Monday. - Blue Water Vaccines, Inc. NASDAQ:BWV fell 7.8% to
$4.9999 after jumping 44% on Monday.